After last year’s record event, BIVDA’s 2026 Regulatory Affairs Seminar will be held on the 10th and 11th February in Birmingham. In a sign of the importance of this event, MHRA Chief Executive Lawrence Tallon will be closing the event with a keynote address.
With prices frozen at the 2025 level, delegates can learn, network, and explore with 120 of the UK and Europe’s leading regulators.
Registration will open shortly, so please save the date and we look forward to welcoming you.
Of the event, BIVDA’s Head of Regulatory Strategy, Professor Mike Messenger, said, “AI, genomics, and next-generation diagnostics are transforming what’s possible for patients, clinicians, and the NHS. But to turn innovation into impact, one must navigate regulation effectively. The BIVDA Regulatory Affairs Seminar in February will unite policymakers, regulators, and industry leaders to tackle the big questions shaping the future of truly personalised medicine. This is where the next chapter of UK diagnostics regulation begins — don’t miss it!”
There are a number of sponsorship opportunities, so if you are interested in showcasing your product or services to the UK’s leading diagnostics regulatory professionals, please contact neil.plumridge@bivda.org.uk.
